Effects of the fibroblast activation protein on the invasion and migration of gastric cancer

Experimental and Molecular Pathology

Volumn 95, Issue 3, 2013, Pages 350-356

  Wang, Rui Fen ^a   Zhang, Li Hong ^b   Shan, Li Hui ^b   Sun, Wen Guang ^c   Chai, Cui Cui ^b   Wu, Hong Mei ^b   Ibla, Juan C ^d   Wang, Li Feng ^a   Liu, Jia Ren ^d  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cancer associated fibroblasts (CAFs); Fibroblast activation protein (FAP); Gastric cancer; MGC 803 cells

Indexed keywords

FIBROBLAST ACTIVATION PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; GELATINASE; SEPRASE; SERINE PROTEINASE; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OMENTUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; TUMOR INVASION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FIBROBLAST; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH; STOMACH TUMOR; STROMA CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; GELATINASES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OMENTUM; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; STOMACH; STOMACH NEOPLASMS; STROMAL CELLS;

EID: 84887566952     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.10.008     Document Type: Article

References (36)

1. Aertgeerts K., et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J. Biol. Chem. 2005, 280:19441-19444.
2. Brennen W.N., et al. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Mol. Cancer Ther. 2012, 11:257-266.
3. Cai J., et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 2012, 33:20-29.
4. Cappellani A., et al. Clinical and biological markers in gastric cancer: update and perspectives. Front. Biosci. (Schol. Ed.) 2010, 2:403-412.
5. Chen H., et al. TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]. Exp. Mol. Pathol. 2009, 87:189-194.
6. Cheng J.D., et al. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002, 62:4767-4772.
7. Cirri P., Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am. J. Cancer Res. 2011, 1:482-497.
8. Cohen S.J., et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 2008, 37:154-158.
9. Dong H.W., et al. beta-Ionone arrests cell cycle of gastric carcinoma cancer cells by a MAPK pathway. Arch. Toxicol. 2013, 87:1797-1808.
10. Forssell J., et al. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin. Cancer Res. 2007, 13:1472-1479.
11. Hugo H., et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol. 2007, 213:374-383.
12. Ishii G., et al. Fibroblasts associated with cancer cells keep enhanced migration activity after separation from cancer cells: a novel character of tumor educated fibroblasts. Int. J. Oncol. 2010, 37:317-325.
13. Ju M.J., et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am. J. Clin. Pathol. 2009, 131:498-510.
14. Kim J.W., et al. Clinicopathological characteristics and predictive markers of early gastric cancer with recurrence. J. Korean Med. Sci. 2009, 24:1158-1164.
15. Kraman M., et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 2010, 330:827-830.
16. Kunz-Schughart L.A., Knuechel R. Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression?. Histol. Histopathol. 2002, 17:599-621.
17. Kunz-Schughart L.A., Knuechel R. Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol. Histopathol. 2002, 17:623-637.
18. Lai D., et al. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Int. J. Oncol. 2012, 41:541-550.
19. Li Y., et al. gamma-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell. J. Nutr. Biochem. 2011, 22:1127-1136.
20. Liu J.R., et al. beta-Ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. Int. J. Cancer 2008, 122:2689-2698.
21. Liu R., et al. Fibroblast activation protein: a potential therapeutic target in cancer. Cancer Biol. Ther. 2012, 13:123-129.
22. Malik A.N., et al. Mitochondrial DNA as a non-invasive biomarker: accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias. Biochem. Biophys. Res. Commun. 2011, 412:1-7.
23. O'Brien P., O'Connor B.F. Seprase: an overview of an important matrix serine protease. Biochim. Biophys. Acta 2008, 1784:1130-1145.
24. Orimo A., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
25. Ostermann E., et al. Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin. Cancer Res. 2008, 14:4584-4592.
26. Saadi A., et al. Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2177-2182.
27. Saigusa S., et al. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int. J. Oncol. 2011, 38:655-663.
28. Santos A.M., et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J. Clin. Invest. 2009, 119:3613-3625.
29. Shan L.H., et al. Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinoma. J. Clin. Pathol. 2012, 65:888-895.
30. Slack G.W., et al. Flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia: correlation with immunocytochemistry and Western blot analysis. Arch. Pathol. Lab. Med. 2007, 131:50-56.
31. Speirs V., et al. Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell. Dev. Biol. Anim. 1996, 32:72-74.
32. Sugiura T., et al. VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Int. J. Oncol. 2009, 34:673-680.
33. Tahtis K., et al. Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. Mol. Cancer Ther. 2003, 2:729-737.
34. Zhang M.Z., et al. Expression of seprase in effusions from patients with epithelial ovarian carcinoma. Chin. Med. J. (Engl.) 2007, 120:663-668.
35. Zhang Y., et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett. 2011, 303:47-55.
36. Zhang H.W., et al. Toxicological insight from AP-1 silencing study on proliferation, migration, and dedifferentiation of rat vascular smooth muscle cell. Cardiovasc. Toxicol. 2012, 12:25-38.